Prostate Cancer

1. Precise minimally invasive treatment , comprehensive treatment plans for younger patients, and excellent postoperative functional protection.

Precise and minimally invasive treatment , comprehensive treatment plans for younger patients, and excellent postoperative functional protection. Prostate cancer diagnosis and treatment in China focuses on male physiological characteristics. The da Vinci robotic minimally invasive surgery is widely used and can precisely avoid nerve and blood vessel damage. The postoperative urinary control and sexual function preservation effects are better than conventional surgery overseas.

2. Mature subtype-based and stratified treatment plans

For early-stage localized prostate cancer, intermediate-stage invasive prostate cancer, and late-stage castration-resistant prostate cancer, we offer comprehensive stratified treatment plans, covering new endocrine drugs, targeted therapies, and radiotherapy regimens, with a cost-effectiveness far exceeding that of Europe and the United States.

3. Overall costs are significantly lower than in Europe and America, with no hidden fees.

China has widely adopted proton and heavy ion therapy and robotic minimally invasive surgery with no hidden fees, significantly reducing the cost of treating serious illnesses . Under the same conditions, the overall cost is usually only one-third of that in Europe and the United States, or even lower.

4. Zero waiting period, rapid medical intervention to avoid delays in treatment.

In Europe, America, Japan, and South Korea, the waiting time for specialist appointments and surgeries at public hospitals is generally 3-12 months, while private institutions are extremely expensive and still have a waiting period of 1-3 months. China has a well-established international medical channel, and prostate cancer patients who come to China for medical tourism through Trisana Medguide can have an in-person consultation within 3 days and start treatment within 7 days, allowing for early admission and early recovery and preventing delays in treatment .

1. Connect with China's top medical resources to accurately and personalizedly match hospitals and specialists.

We connect you directly with China's top 10 tertiary hospitals and academician-level experts, providing you with accurate expert appointments, surgery schedule bookings, and personalized treatment plans, eliminating detours in your medical journey.

2. Rigorous and traceable service processes ensure precise and efficient medical tourism.

From initial consultation and assessment, visa assistance, and itinerary planning, to in-hospital medical coordination, postoperative rehabilitation management, and long-tail services after returning home, every step is managed with standard operating procedures (SOPs).

3. Assemble an elite service team to provide butler-style, one-on-one care throughout the entire process.

Our team comprises six elite professionals with advanced degrees, including medical masters and doctors, specializing in medical consultation, medical translation, visa assistance, health management, information development, and professional care. We offer customized service plans and provide one-on-one concierge-style care throughout the entire process.

4. Integrated medical tourism one-stop fully managed VIP service

We offer full-service concierge services, including private car service, hotel and apartment booking, medical services such as medical escort and translation, and access to expedited medical care, as well as daily care such as housekeeping and customized meals, making patients and their families feel at home and worry-free throughout the entire process.

0.Why are Fudan University Cancer Hospital, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine recommended as the best choice?

Fudan University Cancer Hospital:

(Ye Dingwei Team) A benchmark in the Asia-Pacific region and a leading domestic institution for prostate cancer. Projected surgical volume to exceed 2,500 cases in 2024, ranking first in Shanghai for many consecutive years. Overall 5-year survival rate is 82.6% (nearly 100% for early-stage radical surgery). Urinary continence recovery rate is 97%, and post-nerve-sparing surgery, sexual function recovery within 1 year is >70%, which is superior to the national average of 69.2%.

Technology: The "Fudan Cancer Hospital Technique," uniquely developed to suit the deep pelvis of Chinese patients, utilizes the fourth-generation da Vinci dual-console robot. PSMA+FDG PET-CT detects micro-metastases with 78% accuracy. Nerve-sparing radical prostatectomy accounts for >90% of cases. For advanced stages, the "Fudan Protocol" of sequential targeted therapy, immunotherapy, and domestic relugolix is employed. MDT: Established in 2005, it is the initiator of the Chinese Urological Oncology MDT Platform, with influence extending to over 400 centers. For International Patients: With dual campuses in Xuhui and Pudong, the international department offers English medical record translation and pre-approval for commercial insurance. It is a preferred choice for foreign patients seeking functional preservation for early-stage cancer or transformation for advanced-stage disease.

Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine:

Renji Hospital (Xue Wei/Pan Jiahua/Dong Baijun Team) is ranked first among comprehensive tertiary hospitals in Shanghai for prostate cancer and second in the city for surgical volume. The Urology department performs 27,000 surgeries annually, with robot-assisted radical prostatectomies exceeding 10,000 cases. By 2021, over 4,000 cases had been performed. In 2024, Zhu Yinjie performed 522 cases as a solo surgeon, ranking first in Shanghai, and Xue Wei performed over 500 cases annually as the lead surgeon.

Technology: Radical prostatectomy with maximal preservation of surrounding structures accounts for >90% of cases. The early-stage urinary incontinence rate is reduced to 15% (compared to the international norm of 65%). Single-port robotic surgery is completed in 40 minutes, with discharge within 36 hours. Neoadjuvant therapy combined with extended lymph node dissection is used for high-risk/locally advanced disease. MDT: A fixed linkage between Urology, Oncology, Radiotherapy, and Pathology ensures mature individualized treatment for castration-resistant prostate cancer. For International Patients: Located in Building 15, International Medical Center. Offers services in 16 languages and direct billing for 32 commercial insurances including Cigna, AXA, Bupa, and MSH. Hospitalization requires passport registration and a guarantee letter. Suitable for foreign patients with commercial insurance seeking preservation of urinary control/sexual function, and those with locally advanced disease.

m0:Some representatives of medical experts in prostate cancer:

m1:

doctor:96824205714915329

m2:

doctor:96825106628345858

case:96468079508458497